Clinical trial
Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease (CKD)
NCT03253172 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease (CKD)
- Lead sponsor
- Erasmus Medical Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 1, 2017
- Completion date
- October 1, 2026
- Enrollment
- 532 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hyperkalemia, hypertension, potassium depletion, renal insufficiency, chronic